A panel of Indian experts is investigating if there are any domestic cases of blood clotting, even mild ones, as a side effect of the two COVID-19 vaccines being administered in the country, financial daily Mint reported on Friday.
India is currently administering AstraZeneca's COVID-19 vaccine and a shot developed at home by Bharat Biotech. (https://bit.ly/2OAP4wc)
Several countries in Europe have announced restrictions on the use of the AstraZeneca vaccine in younger people, after a link was found to very rare blood clots, mostly in women under 60 years of age within two weeks of vaccination.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
{{#Source}}{{Source}}{{/Source}}{{#IsBlog}}
{{Disclaimer}}
{{/Disclaimer}}